MDM2 and central nervous system cancer: In the de Novo pathway of glioma occurrence, two crucial oncogenes (EGFR and MDM2) and two important tumor suppressors (PTEN and IKN4a/ARF) were found to be closely correlated with WNT5A in glioma (Figure 8B).